4 - 8
nov 2017
glasgow

Issue Panel Discussion
6th Nov 2017

How to improve consistency of orphan drug pricing and reimbursement in Europe? Application of the ORPH-VAL Principles in Germany, France and UK

read more

14 - 15
nov 2017
Barcelona

Plenary discussion
14th Nov 2017

Using ORPH-VAL principles in assessing the value of orphan medicines:
Correcting the discrepancy between countries

read more

4 - 8
nov 2017
glasgow

Issue Panel Discussion
6th Nov 2017

How to improve consistency of orphan drug pricing and reimbursement in Europe? Application of the ORPH-VAL Principles in Germany, France and UK

read more

14 - 15
nov 2017
Barcelona

Plenary discussion
14th Nov 2017

Using ORPH-VAL principles in assessing the value of orphan medicines:
Correcting the discrepancy between countries

read more

23feb 2017

EURORDIS
2nd multi-stakeholder symposium

Presentation of the ORPH-VAL publication in front of a wide range of rare disease stakeholders.

25feb 2016

EURORDIS
1st multi-stakeholder symposium

Presentation of draft Principles to obtain feedback from a wide range of rare disease stakeholders.

Recommendations for value assessment and funding process in rare diseases” instead of Principles Paper

9 Principles covering recommendations on P&R decision criteria, P&R decision processes, sustainable funding systems and European coordination

read more